Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma
Clinical trial NCT04128072 · RECRUITING
Trial details
- NCT number
- NCT04128072
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-07
- Primary completion
- 2026-10-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.